1. Home
  2. Labeler Index
  3. Nucare Pharmaceuticals,inc.
  4. 68071-4141
  5. Product Images: Losartan Potassium

Product Images Losartan Potassium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Losartan Potassium NDC 68071-4141 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

68071 4141 09 T93

68071 4141 09 T93

This is a description of a pharmaceutical company NuCare Pharmaceuticals, Inc. The text also includes important details like product number, Lot #, expiration date, and NDC code of Losartan Potassium tablets of 100mg. It also warns to keep the tablets out of reach of children and instructs to store them at a controlled temperature of 59-86°F. The rest of the text contains errors and is not understandable.*

Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01

Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01

figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02

figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02

This is a study report comparing the effectiveness of Atenolol and Losartan Potassium Tablets in reducing the risk of a primary endpoint. The primary endpoint percentage of patients is not mentioned, but it is observed that Losartan Potassium Tablets show an adjusted risk reduction of 13% with p-value 0.021. The study was conducted for a duration of 65 months, and measurements were taken for every 6 months from month 0 to month 60, and then at month 65.*

figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03

figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03

The text describes a comparison of Atenolol and Losartan Potassium Tablets in reducing the risk of fatal or non-fatal strokes in patients. The data shows that the adjusted risk reduction for Losartan Potassium Tablets is 25% compared to Atenolol. The study was conducted over several months, as indicated by the timeline at the bottom of the text.*

figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04

figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04

figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05

figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05

This is a summary of a clinical trial for Losartan Potassium Tablets with a placebo group. The only available data is the percentage of patients with an event in each group and the reported risk reduction percentage. The purpose and nature of the event and the number of patients in each group are not provided.*

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.